Investing Profile

Kate Bingham

Photo of Kate Bingham, Managing Partner at SV Health Investors
Harvard Business School Network
423 CONNECTIONS
University of Oxford Network
96 CONNECTIONS
cb
SV Health Investors Managing Partner
$30K - $3.0M
$1.5M
3
£200M
CompanyStageDateRound SizeTotal Raised
Eyebiotech
Series ANov 2023$65M
Series AFeb 2022$65M
SeedAug 2021
$130M
Co-investors: Mike Ross (SV Health Investors), Bernard Davitian (Omega Funds)
Managing Partner SV Life Sciences1991 - Present
Harvard Business School MBA Business
University of Oxford BA Biochemistry